Progesterone 200 mg Troche
Published February 5, 2020 · Recall initiated: December 18, 2019
Summary
FDA records drug Class II recall D-0811-2020, published February 5, 2020 and initiated December 18, 2019. Recalling firm: MPRX, Inc. dba Medical Park Pharmacy; Status: Terminated; Reported quantity: 1 bottle; Lot: Lot: 61242:26 Use by: 02/28/2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- MPRX, Inc. dba Medical Park Pharmacy
- Distributor
- TX
- Lot
- Lot: 61242:26 Use by: 02/28/2020
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDASquaric Acid 0.1% Topical Solution (Clinic) 30 mLFebruary 5, 2020
- FDANaltrexone 4.5 mg capsuleFebruary 5, 2020
- FDALidocaine/Priloc/PE 15/5/0.25% 30 GM jarsFebruary 5, 2020
- FDATadalafil 6 mg CapsuleFebruary 5, 2020
- FDAProgesterone 50 mg capsulesFebruary 5, 2020
- FDAMagic Bullet SupplementFebruary 5, 2020
Questions about this recall
Was Progesterone 200 mg Troche recalled?
Yes. FDA published recall D-0811-2020 on February 5, 2020. Reported hazard: Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.
What should I do if I have this product?
Voluntary: Firm initiated · Letter